Pooled analysis of phase 2 reports of 2 v 1 course of carboplatin as adjuvant for stage 1 seminoma.

被引：0

作者：

Oliver, T

Dieckmann, KP

Steiner, H

Skoneczna, I

机构：

[1] QMUL, St Barts & London Sch Med, London, England

[2] Albertenan Hosp, Hamburg, Germany

[3] Med Univ Innsbruck, Innsbruck, Austria

[4] Inst Oncol, Warsaw, Poland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：395S / 395S

页数：1

共 50 条

[21] Phase 1/2 study of veliparib (V) combined with carboplatin (Cb) and etoposide (E) in patients (pts) with extensive-stage disease (ED) small cell lung cancer (SCLC) and other solid tumors: Phase 1 results.
Atrafi, Florence
Groen, Harry J. M.
Byers, Lauren Averett
Garralda, Elena
Lolkema, Martijn P.
Sangha, Randeep S.
Ramirez, Santiago Viteri
Chae, Young Kwang
Camidge, D. Ross
Gabrail, Nashat Y.
Waskiewicz, Tina
Hu, Beibei
Xu, Tu
Nuthalapati, Silpa
Hoening, Elizabeth
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[22] INVESTIGATION OF M1-PHASE IN SYSTEM V1-XFEXO2
PEBLER, J
SCHMIDT, K
WASINSKI, H
ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES, 1977, 32 (05): : 507 - 512
[23] Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial
Papachristofilou, Alexandros
Bedke, Jens
Hayoz, Stefanie
Schratzenstaller, Ulrich
Pless, Miklos
Hentrich, Marcus
Krege, Susanne
Lorch, Anja
Aebersold, Daniel -M
Putora, Paul Martin
Berthold, Dominik-R
Zihler, Deborah
Zengerling, Friedemann
Dieing, Annette
Mueller, Arndt -Christian
Schaer, Corinne
Biaggi, Christine
Gillessen, Silke
Cathomas, Richard
LANCET ONCOLOGY, 2022, 23 (11): : 1441 - 1450
[24] Safety profile of avelumab in patients with advanced solid tumors: A JAVELIN pooled analysis of phase 1 and 2 data.
Kelly, Karen
Infante, Jeffrey R.
Taylor, Matthew H.
Patel, Manish R.
Gordon, Michael S.
Wong, Deborah Jean Lee
Iannotti, Nicholas
Mehnert, Janice M.
Loos, Anja
Koch, Helga
Speit, Isabel
Gulley, James L.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[25] New line positions analysis of the v1+v2+v3 band of NO2 at 3637.848 cm-1
Gueye, F.
Tchana, E. Kwabia
Landsheere, X.
Perrin, A.
JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER, 2014, 138 : 60 - 69
[26] High resolution analysis of the SO2 spectrum in the 2600-2900 cm-1 region: 2v3, v2+2v3-v2 and 2v1+v2 bands
Ulenikov, O. N.
Gromova, O. V.
Bekhtereva, E. S.
Bolotova, I. B.
Konov, I. A.
Horneman, V. -M.
Leroy, C.
JOURNAL OF QUANTITATIVE SPECTROSCOPY & RADIATIVE TRANSFER, 2012, 113 (07): : 500 - 517
[27] SIMULTANEOUS ANALYSIS OF V1+V2 AND V2+V3 BANDS OF HYDROGEN TELLURIDE
MONCUR, NK
WILLSON, PD
EDWARDS, TH
JOURNAL OF MOLECULAR SPECTROSCOPY, 1974, 52 (02) : 181 - 195
[28] B-Raf V600E harboring non-melanoma cancers treated with Vemurafenib monotherapy and in combination with Everolimus/Sorafenib/Crizotinib/Paclitaxel plus Carboplatin: A pooled analysis of five phase 1/2 studies.
Nelson, Blessie Elizabeth
Roszik, Jason
Janku, Filip
Hong, David
Kato, Shumei
Naing, Aung
Piha-Paul, Sarina
Fu, Siqing
Tsimberidou, Apostolia
Cabanillas, Maria
Busaidy, Naifa
Javle, Milind
Byers, Lauren
Heymach, John
Meric-Bernstam, Funda
Subbiah, Vivek
CANCER RESEARCH, 2022, 82 (12)
[29] First analysis of the 2v1+3v3 band of NO2 at 7192.159 cm-1
Raghunandan, R.
Perrin, A.
Ruth, A. A.
Orphal, J.
JOURNAL OF MOLECULAR SPECTROSCOPY, 2014, 297 : 4 - 10
[30] POSTSURGERY ADJUVANT IMMUNOTHERAPY OF STAGE-1 AND 2, AND PRE-CHEMOTHERAPY ADJUVANT IMMUNOTHERAPY OF STAGE-3 AND 4 BRONCHUS CARCINOMA
POUILLART, P
MATHE, G
PALANGIE, T
HUGUENIN, P
MORIN, P
GAUTIER, H
BARON, A
LEDEDENTE, A
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 341 - 341

← 1 2 3 4 5 →